Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole

Detalhes bibliográficos
Autor(a) principal: Rodrigues Alves, Nuno
Data de Publicação: 2024
Outros Autores: Duarte, Ana Filipa, Ribeiro, David Fernandes, Silva, Rita Sousa, Carvalho, Bruno Almeida, Alpuim Costa, Diogo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/163611
Resumo: Funding Information: The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The funding was for open access publication fee. Payed by CUF Oncology. Publisher Copyright: Copyright © 2024 Rodrigues Alves, Duarte, Ribeiro, Silva, Carvalho and Alpuim Costa.
id RCAP_bffb9676050bad4cd28328a4f5b516c7
oai_identifier_str oai:run.unl.pt:10362/163611
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozolea case report and literature reviewabemaciclibbreast cancercase reportCDK4/6 inhibitorletrozolemetastasesorbitreviewOncologyCancer ResearchSDG 3 - Good Health and Well-beingFunding Information: The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The funding was for open access publication fee. Payed by CUF Oncology. Publisher Copyright: Copyright © 2024 Rodrigues Alves, Duarte, Ribeiro, Silva, Carvalho and Alpuim Costa.Breast cancer is a significant global health concern, contributing to substantial morbidity and mortality among women. Hormone receptor-positive (HR+)/HER2-negative (HER2-) breast cancer constitutes a considerable proportion of cases, and significant advancements have been made in its management. CDK4/6 inhibitors (CDK4/6is) are a new targeted therapy that has demonstrated efficacy in adjuvant, advanced and metastatic settings. The propensity of lobular breast carcinomas for estrogen-rich sites, such as periocular tissues and orbital fat, may explain their tendency for orbital metastases. Current treatment strategies for these cases are predominantly palliative, and the prognosis remains poor. This article presents a unique case of a 51-year-old female with progressive right periorbital edema, pain, and limited ocular motility. An imaging work-up showed bilateral intra and extraconal orbital infiltration, which was biopsied. The histopathologic analysis disclosed mild chronic inflammatory infiltrate with thickened fibrous tissue and moderately differentiated lobular carcinoma cells, positive for GATA3 and CK7 markers, with 100% of tumor nuclei expressing estrogen receptors (ER+). A systemic evaluation showed a multicentric nodular formation in both breasts. Further diagnostic assessments unveiled an HR+/HER2- bilateral lobular breast carcinoma with synchronous bilateral orbital metastases. Systemic treatment was initiated with abemaciclib 150mg twice daily and letrozole 2.5mg once a day. However, this regimen was interrupted due to toxicity. After two weeks, treatment was resumed with a reduced abemaciclib dose (100mg twice daily) alongside letrozole, with a reasonable tolerance. Nearly two years after the initial diagnosis of inoperable metastatic cancer, the patient remains on the same systemic treatment regimen with no signs of invasive disease. This case report is the first of a patient presenting with bilateral orbital metastases from bilateral lobular breast cancer, showing an impressive and sustained response to a first-line treatment regimen combining abemaciclib and letrozole. A literature review on bilateral orbital metastases from breast cancer is also presented.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNRodrigues Alves, NunoDuarte, Ana FilipaRibeiro, David FernandesSilva, Rita SousaCarvalho, Bruno AlmeidaAlpuim Costa, Diogo2024-02-16T01:13:01Z20242024-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/163611eng2234-943XPURE: 83467732https://doi.org/10.3389/fonc.2024.1286910info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:47:47Zoai:run.unl.pt:10362/163611Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:59:46.221707Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole
a case report and literature review
title Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole
spellingShingle Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole
Rodrigues Alves, Nuno
abemaciclib
breast cancer
case report
CDK4/6 inhibitor
letrozole
metastases
orbit
review
Oncology
Cancer Research
SDG 3 - Good Health and Well-being
title_short Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole
title_full Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole
title_fullStr Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole
title_full_unstemmed Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole
title_sort Successful management of bilateral orbital metastases from invasive lobular breast cancer with abemaciclib and letrozole
author Rodrigues Alves, Nuno
author_facet Rodrigues Alves, Nuno
Duarte, Ana Filipa
Ribeiro, David Fernandes
Silva, Rita Sousa
Carvalho, Bruno Almeida
Alpuim Costa, Diogo
author_role author
author2 Duarte, Ana Filipa
Ribeiro, David Fernandes
Silva, Rita Sousa
Carvalho, Bruno Almeida
Alpuim Costa, Diogo
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Rodrigues Alves, Nuno
Duarte, Ana Filipa
Ribeiro, David Fernandes
Silva, Rita Sousa
Carvalho, Bruno Almeida
Alpuim Costa, Diogo
dc.subject.por.fl_str_mv abemaciclib
breast cancer
case report
CDK4/6 inhibitor
letrozole
metastases
orbit
review
Oncology
Cancer Research
SDG 3 - Good Health and Well-being
topic abemaciclib
breast cancer
case report
CDK4/6 inhibitor
letrozole
metastases
orbit
review
Oncology
Cancer Research
SDG 3 - Good Health and Well-being
description Funding Information: The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The funding was for open access publication fee. Payed by CUF Oncology. Publisher Copyright: Copyright © 2024 Rodrigues Alves, Duarte, Ribeiro, Silva, Carvalho and Alpuim Costa.
publishDate 2024
dc.date.none.fl_str_mv 2024-02-16T01:13:01Z
2024
2024-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/163611
url http://hdl.handle.net/10362/163611
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2234-943X
PURE: 83467732
https://doi.org/10.3389/fonc.2024.1286910
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138174399676416